Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience.
Cancers (Basel)
; 14(7)2022 Mar 29.
Article
in En
| MEDLINE
| ID: mdl-35406512
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Cancers (Basel)
Year:
2022
Document type:
Article
Affiliation country:
España
Country of publication:
Suiza